VeraCept IUD Study
This study is closed to recruitment, and is no longer screening new participants.
This study is being conducted at the University of Pennsylvania to research a low-dose copper contraceptive that is placed in the uterus and is intended to prevent pregnancy, known as VeraCept. This device is experimental and is being developed as a possible method of long-acting reversible contraception. “Experimental” means that VeraCept has not yet been approved by the Food and Drug Administration (FDA) for sale in the United States.
The study will investigate the safety and effectiveness of VeraCept in preventing pregnancy. We will also be looking at any effects on menstrual cycle periods and bleeding, and assess any side effects. Study participation involves 6 visits over approximately one year, as well as monthly telephone calls and completion of a daily diary chart.
Healthy women ages 18 - 40
Have regular menstrual periods
Willing to use the study device as their only method of birth control during the study
Not seeking pregnancy for at least 1 year
Sexually active with a regular male partner
Qualified participants will receive:
$50-75 per completed study visit (a maximum of $850)
Investigational intrauterine contraceptive device
Dr. Courtney Schreiber, MD, MPH